Income Taxes (Tables)
|
6 Months Ended |
Mar. 31, 2026 |
| Income Taxes [Abstract] |
|
| Schedule of Income Tax Expenses |
The income tax expenses consist of the following
components:
| | |
For the six months ended March 31, | |
| | |
2026 | | |
2025 | |
| Current income tax expenses | |
$ | — | | |
| 340,441 | |
| Deferred income tax benefit | |
| — | | |
| — | |
| Total income tax expenses | |
$ | — | | |
$ | 340,441 | |
|
| Schedule of Provision for Income Taxes and the Provision at Japan Statutory Rate |
A reconciliation between the Group’s actual
provision for income taxes and the provision at Japan statutory rate is as follows:
| | |
For the six months ended March 31, | |
| | |
2026 | | |
2025 | |
| Loss before income tax expenses | |
$ | (1,670,078 | ) | |
$ | (2,746,918 | ) |
| Computed income tax benefit with statutory tax rate | |
| (615,034 | ) | |
| (1,011,597 | ) |
| Effect of preferential tax rate | |
| 19 | | |
| (21,205 | ) |
| Impact of different tax rates in other jurisdictions | |
| 214,875 | | |
| 821,728 | |
| Non-deductible expenses | |
| 16,601 | | |
| 2,988 | |
| Utilized tax gain | |
| — | | |
| — | |
| Changes in valuation allowance | |
| 383,539 | | |
| 548,527 | |
| Income tax expenses | |
$ | — | | |
$ | 340,441 | |
|
| Schedule of Significant Components of the Deferred Tax Assets |
As of March 31, 2026 and September 30,
2025, the significant components of the deferred tax assets are summarized below:
| | |
As of March 31, 2026 | | |
As of September 30, 2025 | |
| Deferred tax assets: | |
| | |
| |
| Net operating loss carried forward | |
$ | 2,880,266 | | |
$ | 2,479,634 | |
| Unrealized foreign exchange loss | |
| (43,244 | ) | |
| (30,668 | ) |
| Total deferred tax assets | |
| 2,837,022 | | |
| 2,448,966 | |
| Valuation allowance | |
| (2,837,022 | ) | |
| (2,448,966 | ) |
| Deferred tax assets, net of valuation allowance | |
$ | — | | |
$ | — | |
|
| Schedule of Changes in Valuation Allowance |
Changes in valuation allowance are as follows:
| | |
As of March 31, 2026 | | |
As of September 30, 2025 | |
| Valuation allowance: | |
| | |
| |
| Balance at beginning of the year | |
$ | 2,448,966 | | |
$ | 1,310,463 | |
| Additions | |
| 382,859 | | |
| 1,157,678 | |
| Loss utilized | |
| — | | |
| — | |
| Exchange difference | |
| 5,197 | | |
| (19,175 | ) |
| Balance at end of the year | |
$ | 2,837,022 | | |
$ | 2,448,966 | |
|
| Schedule of Net Operating Loss Carryforwards |
As of March 31, 2026 net operating loss carryforwards
will expire, if unused, in the following amounts:
| 2026 | |
$ | 146,286 | |
| 2027 | |
| 514,331 | |
| 2028 | |
| 1,592,564 | |
| 2029 | |
| 1,689,118 | |
| 2030 | |
| 7,480,918 | |
| 2031 | |
| 1,374,204 | |
| Total | |
$ | 12,797,421 | |
|